Historique
Rapport
EMCDDA-Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012) : In accordance with Article 10 of Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances
Auteur(s) :
Europol ;
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction)
Année :
2013
Page(s) :
44 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
Collection :
Implementation reports
ISBN :
978-92-9168-650-6
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAR (Marchés / Markets)
Thésaurus mots-clés
DROGUES DE SYNTHESE
;
SURVEILLANCE EPIDEMIOLOGIQUE
;
CATHINONES
;
INTERNET
;
DIFFUSION DES PRODUITS
;
CANNABINOIDES
;
CONTROLE DES STUPEFIANTS
;
AVERTISSEMENT SANITAIRE
;
MEPHEDRONE
;
PHARMACOVIGILANCE
;
PHENOMENE EMERGENT
;
PRODUCTION
;
DEFINITION
;
ANALYSE CHIMIQUE
Thésaurus géographique
EUROPE
Organismes
OEDT
Note de contenu :
TABLE OF CONTENTS:
• Introduction and background
• Implementation arrangements and cooperation with the EU Pharmacovigilance system
• Formal activities
• Epidemiology and new approaches
• Production and distribution of new psychoactive substances
• Conclusions
• Annexes
• Introduction and background
• Implementation arrangements and cooperation with the EU Pharmacovigilance system
• Formal activities
• Epidemiology and new approaches
• Production and distribution of new psychoactive substances
• Conclusions
• Annexes
Résumé :
FRANÇAIS :
Le rapport annuel 2013 OEDT-Europol, qui fait le point sur les nouvelles drogues, indique que le nombre, le type et la disponibilité des nouvelles drogues en Europe ont continué à croître en 2012. Elles étaient au nombre de 49 en 2011, de 41 en 2010 et de 24 en 2009. La liste des substances signalées en 2012 était dominée par 30 cannabinoïdes de synthèse, des substances qui simulent les effets du cannabis.
ENGLISH:
The unprecedented growth in the number, type and availability of new drugs over the past few years has seen the phenomenon take on global significance. Overall, the number of substances notified in the last two years accounts for more than half of the total number of substances notified to the EU Early warning system since May 2005. Driven by globalisation, technological advancement and the Internet, an open market for new drugs has now developed which presents challenges to public health, law enforcement and policy making.
The rapid appearance of non-controlled alternatives to controlled drugs underlines the ability of the market to respond to changes in the legal status of psychoactive substances and has been accompanied, in some cases, by serious adverse health consequences. It is well established that organised crime is involved in some of these activities and continues to exploit the opportunities presented by the market in new drugs.
This report presents the key activities performed by the EMCDDA and Europol in 2012 and includes details of all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances.
Le rapport annuel 2013 OEDT-Europol, qui fait le point sur les nouvelles drogues, indique que le nombre, le type et la disponibilité des nouvelles drogues en Europe ont continué à croître en 2012. Elles étaient au nombre de 49 en 2011, de 41 en 2010 et de 24 en 2009. La liste des substances signalées en 2012 était dominée par 30 cannabinoïdes de synthèse, des substances qui simulent les effets du cannabis.
ENGLISH:
The unprecedented growth in the number, type and availability of new drugs over the past few years has seen the phenomenon take on global significance. Overall, the number of substances notified in the last two years accounts for more than half of the total number of substances notified to the EU Early warning system since May 2005. Driven by globalisation, technological advancement and the Internet, an open market for new drugs has now developed which presents challenges to public health, law enforcement and policy making.
The rapid appearance of non-controlled alternatives to controlled drugs underlines the ability of the market to respond to changes in the legal status of psychoactive substances and has been accompanied, in some cases, by serious adverse health consequences. It is well established that organised crime is involved in some of these activities and continues to exploit the opportunities presented by the market in new drugs.
This report presents the key activities performed by the EMCDDA and Europol in 2012 and includes details of all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances.
Titre précédent :